Vascular Replacement

Slide 1 · Vascular Replacement

Conduit selection, graft adaptation, and mechanisms of failure

Graft

Native vessel

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Distinguish vessel replacement from bypass of an obstructed artery.

Explain why graft diameter and flow context affect synthetic-conduit success.

Recognize thrombosis, neointimal hyperplasia, and vein-graft atherosclerosis.

Compare autologous saphenous vein and internal mammary artery graft outcomes.

Slide 3 · Why a vessel is reconstructed

A damaged vessel may require an interposed conduit to restore continuity.

A diseased artery may instead be bypassed to route flow around the obstructed segment.

Both strategies create interfaces between a conduit and native vasculature.

Long-term success requires the conduit and its anastomoses to remain patent.

Slide 4 · Replacement and bypass are distinct arrangements

Damaged segment

Remove or exclude segment

Interposed conduit

Continuity restored

Replacement: Graft bridges an interrupted pathway

Flow-limiting disease

Native lesion retained

Parallel graft route

Distal flow restored

Bypass: Graft provides an alternate pathway

Slide 5 · Conduits: Synthetic or autologous

Source

Example

Teaching distinction

Synthetic

Large-bore vascular prosthesis

Useful in high-flow, large-caliber locations

Autologous vein

Saphenous vein

Used as a small-bore bypass conduit

Autologous artery

Internal mammary artery

Typically used for LAD bypass

Slide 6 · Graft caliber changes the problem

Large-bore conduit

Example: 12–18 mm synthetic conduit

Works well in the high-flow aorta

A functional setting for synthetic material

Small-bore conduit

Small-diameter artificial conduits often fail

Early thrombosis is one mechanism

Late intimal hyperplasia is another

Slide 7 · Large synthetic grafts: Favorable context

The aorta is the cited high-flow location for synthetic replacement.

12–18 mm conduits functioning well in this setting.

This success should not be extrapolated to narrow arteries.

Conduit performance is site- and caliber-dependent.

Aortic context: Large bore + high flow

Slide 8 · Large and small conduits are not equivalent

Synthetic material

Large aortic conduit

Favorable reported function

Same material class; Very different vascular setting

Synthetic material

Small-caliber graft

Frequent failure

Failure mechanisms: Thrombosis and neointimal hyperplasia

Slide 9 · Small synthetic grafts: Two dominant liabilities

Early failure

Thrombotic obstruction

Loss of a patent blood channel

Temporal emphasis: Early

Late failure

Intimal hyperplasia

Often at the native vessel–graft junction

Progressive luminal narrowing

Slide 10 · Two paths to lost graft patency

Small synthetic graft

Early thrombus

Luminal obstruction

Thrombotic route

Graft–native junction

Neointimal proliferation

Progressive stenosis

Proliferative route

Slide 11 · The anastomosis is a vulnerable interface

Synthetic conduit

Native artery

Anastomotic intimal overgrowth

Neointimal accumulation occurs at the junction with native vasculature.

Schematic only — not a micrograph, angiogram, or to-scale model.

Slide 12 · Early graft thrombosis: The anatomic endpoint

Open lumen

Partial thrombus

Thrombotic occlusion

Schematic: A thrombus can reduce or obstruct the graft lumen.

Original simplified cross-section; Not a histologic image.

Slide 13 · Delayed stenosis: A different mechanism

Patent junction

Growing neointima

Severe narrowing

Schematic: Intimal tissue accumulates inward over time.

Original simplified cross-section; Not a histologic image.

Slide 14 · Graft–artery junction: Neointimal tissue

Synthetic conduit

Native artery

Anastomotic intimal overgrowth

Late intimal proliferation can leave a very small residual lumen.

Schematic only — not a micrograph, angiogram, or to-scale model.

Slide 15 · Source figure 11.34: What the angiogram shows

The cited example is a synthetic femoral–popliteal graft.

Angiography demonstrates a constriction at the distal anastomosis.

The arrow in the described source figure identifies the constricted region.

Angiographic narrowing identifies the level of obstruction, not its cellular composition.

Morphologic evidence described; Original image not supplied.

Slide 16 · Source figure 11.34: What microscopy adds

A Gore-Tex graft is identified at the anastomosis.

Prominent intimal proliferation lies adjacent to the graft.

The residual lumen is very small in the reported photomicrograph.

Histology establishes tissue overgrowth as the cause of narrowing in this example.

The slide summarizes a source-caption finding; It does not reproduce a photomicrograph.

Slide 17 · Luminal compromise has a structural basis

Broad residual lumen

Concentric thickening

Small residual lumen

Schematic cross-sections: Tissue occupies space previously available for flow.

Original simplified cross-section; Not a histologic image.

Slide 18 · Different lesions converge on reduced flow

Thrombus

Graft lumen obstructed

Reduced distal flow

Early clot

Neointima

Anastomotic stenosis

Reduced distal flow

Delayed proliferative narrowing

Slide 19 · Intimal hyperplasia is a wound-healing response

Vascular injury can disrupt or impair endothelial cells.

Healing recruits smooth muscle cells and stimulates extracellular-matrix synthesis.

Repair tissue collects in the intima as neointima.

In a blood vessel, an otherwise reparative response can compromise flow.

Slide 20 · An intact endothelium resists thrombosis

Normal endothelial cells maintain a relatively nonthrombogenic surface.

Endothelial mediators regulate coagulation, fibrinolysis, and vascular tone.

Injury or dysfunction can shift the surface toward thrombogenicity.

This framework helps distinguish early clotting from late structural stenosis.

Slide 21 · Endothelial injury alters the graft environment

Endothelial loss or dysfunction

Prothrombotic surface

Thrombus formation

Immediate hazard

Endothelial injury

Repair signals activated

Smooth muscle response

Delayed reparative response

Slide 22 · Smooth muscle cells enter the intima

Vascular injury

Medial SMC recruitment

Migration into intima

SMC proliferation

One pathway producing neointimal cellularity

Slide 23 · A proliferative smooth muscle phenotype emerges

Medial SMC

Primarily contractile phenotype

Part of the vessel media

Maintains vessel-wall function

Neointimal SMC

More proliferative phenotype

Greater biosynthetic activity

Reduced contractile function

Slide 24 · Extracellular matrix amplifies neointimal bulk

Activated SMCs

Extracellular-matrix synthesis

Intimal tissue expansion

Reduced residual lumen

Cellular activation becomes an anatomic stenosis

Slide 25 · Neointima: Cells plus matrix

Component

Origin

Functional consequence

Smooth muscle cells

Medial or circulating precursors

Intimal cell accumulation

Extracellular matrix

Synthesized by activated SMCs

Increases thickness of neointima

Endothelial lining

Restored from local cells or precursors

Can modulate the proliferative response

Slide 26 · Which signals promote smooth muscle activation?

Platelets, endothelial cells, and macrophages release cytokines and growth factors.

Thrombin and activated complement also contribute.

These signals favor smooth muscle migration, proliferation, and matrix production.

The mediators act in a vascular injury-repair program, not a graft-specific disease.

Slide 27 · Neointimal growth may eventually stabilize

Endothelial cells can migrate from nearby intact endothelium.

Circulating endothelial precursors can also contribute to repair.

With restoration or normalization of the endothelial layer, neointimal SMCs may become nonproliferative.

An established stenosis can nevertheless persist after the stimulus subsides.

Slide 28 · The paradox: Healing that narrows a vessel

Wall injury

SMC and ECM repair

Neointima

Less space for blood

A reparative tissue response can impair a vascular function.

Slide 29 · Intimal thickening is not unique to grafts

Setting

Shared substrate

Potential effect

Surgical grafting

Neointimal SMCs + ECM

Anastomotic narrowing

Endovascular stenting

Neointimal SMCs + ECM

In-stent restenosis

Vasculitis / graft rejection vasculopathy

Vascular injury response

Luminal stenosis

Slide 30 · Graft stenosis versus in-stent restenosis

Surgical graft

Injury at graft–native interface

Neointimal narrowing at anastomosis

Operative conduit remains a distinct structure

Endovascular stent

Injury follows angioplasty / implantation

SMC growth occurs inside stented region

Metallic scaffold remains in native vessel

Slide 31 · A coronary stent is not vascular replacement

A stent expands within a native coronary artery after angioplasty.

It can stabilize intimal flaps and mechanically support the lumen.

A bypass graft creates a new blood-flow route around a diseased segment.

Both interventions can be limited by proliferative intimal thickening.

Slide 32 · Coronary bypass requires small conduits

The coronary arterial bed requires relatively small-bore conduits.

Synthetic small-diameter grafts have unfavorable thrombosis and hyperplasia performance in the text.

Autologous saphenous veins and internal mammary arteries are therefore important options.

The textbook contrasts these choices using 10-year graft patency.

Slide 33 · Autologous saphenous vein graft

The saphenous vein is harvested from the patient’s leg.

The vein is used to fashion a conduit for coronary bypass.

It can develop early thrombosis, progressive intimal thickening, and later atherosclerosis.

These distinct lesions explain why vein-graft patency declines over time.

Slide 34 · A saphenous vein creates an alternate route

Schematic coronary circulation and bypass route

Aorta

Native coronary artery / LAD territory

Disease

Saphenous vein graft

Slide 35 · Saphenous vein failure is not one lesion

Saphenous graft

Early thrombosis

Occlusion

Thrombotic

Saphenous graft

Intimal thickening

Stenosis

Proliferative

Saphenous graft

Atherosclerosis

Late complications

Atheromatous

Slide 36 · Early saphenous graft loss: Thrombosis

Thrombosis is described as a typical early cause of saphenous graft occlusion.

An intraluminal thrombus can prevent flow through an otherwise intact conduit.

An early loss of patency should not automatically be attributed to atherosclerosis.

Mechanism and timing should be considered together.

Slide 37 · Months to years: Intimal thickening

The textbook places vein-graft intimal thickening on a months-to-years timescale.

Neointimal cells and matrix progressively occupy luminal area.

This is related mechanistically to the stereotyped vascular injury response.

The lesion differs from an acute luminal clot.

Slide 38 · Vein graft atherosclerosis is a late threat

Atherosclerosis can develop in a saphenous vein graft.

This process is distinct from a purely proliferative neointimal lesion.

An atherosclerotic graft lesion may become complicated.

Plaque rupture, thrombosis, and aneurysms among possible complications.

Slide 39 · Plaque rupture can complicate a graft lesion

Vein graft atherosclerosis

Plaque complication / rupture

Superimposed thrombus

Possible occlusion

Rupture and thrombosis as possible late events.

Slide 40 · A thrombus may be early—or superimposed late

Primary early thrombosis

Typically associated with early graft loss

May occur before marked graft atherosclerosis

Direct intraluminal obstruction

Thrombosis over plaque

Occurs in atherosclerotic vein graft disease

Can follow plaque rupture

Late thrombosis superimposed on a chronic lesion

Slide 41 · Aneurysm is another possible graft complication

Aneurysms among complications of vein-graft atherosclerosis.

An aneurysm concerns pathologic vessel-wall dilation rather than simple luminal narrowing.

A graft may therefore fail through mechanisms other than stenosis alone.

Do not equate every late graft abnormality with neointimal hyperplasia.

Slide 42 · Vein-graft disease evolves along several paths

Early

Thrombosis

Months–years

Intimal thickening

Later

Atherosclerotic disease ± rupture / thrombosis / aneurysm

Textbook pattern; Phases can overlap and are not rigid diagnostic cutoffs.

Slide 43 · Saphenous graft: Long-term patency

Average reported 10-year patency is approximately 50%.

The figure refers to grafts remaining open, not patient survival.

The cumulative outcome reflects multiple mechanisms of graft loss.

The text does not provide a full Kaplan–Meier curve or intermediate time points.

~50% patent at 10 years (source statement).

Slide 44 · Internal mammary artery graft

The internal mammary artery is an autologous arterial conduit.

It is described as typically used for bypass to the left anterior descending artery.

Its reported long-term patency exceeds that of saphenous vein grafts.

This comparison is based on the textbook’s 10-year patency statements.

Slide 45 · Internal mammary artery to LAD: Schematic

Schematic coronary circulation and bypass route

Aorta

Native coronary artery / LAD territory

Disease

Internal mammary

Arterial graft

The route is conceptual; LAD use and autologous arterial conduit are sourced.

Slide 46 · Internal mammary grafts: 10-year outcome

More than 90% of internal mammary artery grafts are patent at 10 years in the cited text.

The statement is a lower-bound comparison rather than an exact 90% estimate.

The text also notes a usual anatomical limitation: LAD bypass.

Do not generalize this figure to every target vessel and graft configuration.

>90% patent at 10 years (source statement).

Slide 47 · Two autologous conduits: 10-year patency

Source-reported graft patency at 10 years

0%

50%

100%

Saphenous vein

Internal mammary artery

~50%

>90%

Bar 2 stops at the 90% threshold: The source reports a value above that bound.

Slide 48 · What the patency numbers do—and do not—mean

Textbook statement

Supported inference

Not supplied

Vein graft ~50% at 10 years

About half remain patent at that point

Year-by-year failure rates

Internal mammary >90% at 10 years

Substantially higher patency in the cited setting

An exact point estimate above 90%

Comparison of conduit types

Relevant to selection and counseling

Randomized matched-comparison estimates

Slide 49 · Conduit choice reflects anatomy and failure mode

Setting

Conduit emphasized

Reason supported by text

Aortic replacement

Large synthetic graft

Good function in large, high-flow setting

Small-bore coronary bypass

Saphenous vein

Autologous option where small synthetics fare poorly

Bypass to LAD

Internal mammary artery

High 10-year patency; Typical LAD use

Slide 50 · Failure mechanisms across conduit classes

Material / site

Highlighted hazard

Pathologic substrate

Small synthetic graft

Early obstruction

Thrombosis

Graft–native anastomosis

Delayed stenosis

Neointimal SMC/ECM accumulation

Saphenous vein graft

Late disease

Atherosclerosis ± plaque complication

Internal mammary artery graft

Relatively favorable 10-year patency

No specific failure mechanism quantified in excerpt

Slide 51 · Case 1: Femoral–popliteal graft narrowing

Illustrative teaching vignette

A patient with a synthetic femoral–popliteal bypass develops a focal narrowing at its distal connection to the native artery. Tissue sampling shows marked intimal proliferation and a tiny residual lumen.

What process best explains the narrowing?

Slide 52 · Case 1: Diagnosis from the tissue pattern

Distal anastomosis localizes the lesion to the graft–native interface.

Prominent intimal proliferation with a tiny residual lumen favors anastomotic intimal hyperplasia.

The mechanism is neointimal SMC accumulation and matrix synthesis.

This is the pathologic pattern figure 11.34.

Slide 53 · Case 2: Delayed coronary vein-graft occlusion

Illustrative teaching vignette

A coronary bypass using a saphenous vein remains patent initially but develops progressive narrowing over subsequent years. The specimen contains a thickened intima without evidence of an acute occlusive clot.

Which graft-related process is most directly illustrated?

Slide 54 · Case 2: Distinguish thickening from thrombosis

The long interval and increasing intimal tissue favor a proliferative process.

Neointimal SMCs and ECM contribute to progressive luminal compromise.

Thrombosis is a different lesion, although it may arise at other stages.

Atherosclerosis should not be diagnosed solely from the presence of intimal thickening.

Slide 55 · Case 3: Comparison of coronary conduits

Illustrative teaching vignette

Two graft options are being discussed for coronary bypass: Saphenous vein and internal mammary artery. The target is the left anterior descending coronary artery.

Which textbook patency comparison is appropriate at 10 years?

Slide 56 · Case 3: Interpret the 10-year comparison

The internal mammary artery is typically used for the LAD.

The source reports >90% 10-year patency for internal mammary grafts.

Saphenous vein grafts average about 50% patency at 10 years.

The difference is a descriptive textbook comparison—not an individualized prognosis.

Slide 57 · Reading a graft problem: Morphology first

Identify graft type

Locate abnormality

Classify lesion

Interpret timing

Thrombus · neointima · atheroma · aneurysmal change

Slide 58 · Integrating conduit, lesion, and time

Clue

Most direct interpretation

Important caution

Acute graft obstruction

Consider thrombosis

Timing alone is not histologic proof

Anastomotic tissue overgrowth

Intimal hyperplasia

Do not call it a plaque without evidence

Atheromatous graft lesion

Vein-graft atherosclerosis

May develop rupture and thrombosis

Focal graft dilation

Possible aneurysmal disease

Not interchangeable with stenosis

Slide 59 · Vascular replacement: Mechanistic synthesis

Conduit choice

Endothelial / wall response

Thrombus or neointima

Long-term patency

Late vein-graft atherosclerosis adds a separate pathway.

Slide 60 · Final synthesis

Large, high-flow synthetic grafts have a different performance profile from small synthetic conduits.

Graft loss can reflect early thrombosis, delayed intimal hyperplasia, or vein-graft atherosclerosis.

Neointimal SMCs and ECM explain anastomotic luminal narrowing.

At 10 years, the textbook reports ~50% saphenous versus >90% internal mammary graft patency.